Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Huzhou Haiwang Health Industry Development is a subsidiary of the Shenzhen Neptunus Group, a prominent Chinese pharmaceutical and healthcare conglomerate. Based in Huzhou, Zhejiang, the company is primarily involved in the investment and development of health industry projects, including pharmaceutical manufacturing and healthcare infrastructure. It supports the parent company's broader mission of providing integrated healthcare solutions, ranging from drug R&D to retail pharmacy chains. The Huzhou facility serves as a strategic hub for Neptunus's industrial operations in the East China region. By leveraging the industrial advantages of the Yangtze River Delta, the entity enhances the group's supply chain efficiency and regional footprint. Its operations are a key component of the Neptunus "Big Health" strategy, which integrates pharmaceutical production with modern healthcare services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huzhou Haiwang Health Industry Development.